A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia

被引：0
|
作者：
Julie M. Janssen
T. P. C. Dorlo
D. Niewerth
A. J. Wilhelm
C. M. Zwaan
J. H. Beijnen
A. Attarbaschi
A. Baruchel
F. Fagioli
T. Klingebiel
B. De Moerloose
G. Palumbo
A. von Stackelberg
G. J. L. Kaspers
A. D. R. Huitema
机构：
[1] Netherlands Cancer Institute-Antoni van Leeuwenhoek,Department of Pharmacy and Pharmacology
[2] VU University Medical Center,Department of Pediatric Oncology/Hematology
[3] VU University Medical Center,Department of Clinical Pharmacology and Pharmacy
[4] Princess Maxima Center for Pediatric Oncology,Department of Pediatric Oncology/Hematology
[5] Erasmus-MC Sophia Children’s Hospital,Utrecht Institute for Pharmaceutical Sciences (UIPS)
[6] Utrecht University,Department of Pediatric Hematology and Oncology
[7] St. Anna Children’s Hospital,Department of Pediatrics and Adolescent Medicine
[8] Medical University Vienna,Department of Pediatric Hematology
[9] Hopital Saint Louis,Department of Pediatrics
[10] Università degli Studi di Torino,Department of Pediatrics
[11] University Hospital Frankfurt,Department of Pediatric Oncology/Hematology
[12] Ghent University Hospital,Department of Clinical Pharmacy, University Medical Center Utrecht
[13] Ospedale Pediatrico Bambino Gesù,undefined
[14] Charité Universitätsmedizin,undefined
[15] Utrecht University,undefined
[16] ITCC Consortium,undefined
来源：
Clinical Pharmacokinetics | 2020年 / 59卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：207 / 216
页数：9
相关论文
共 50 条
  • [21] Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia in Adult Patients
    Oriol, Albert
    ACTA HAEMATOLOGICA, 2015, 133 (01) : 89 - 90
  • [22] Blinatumomab in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
    Queudeville, Manon
    Schlegel, Patrick
    Heinz, Amadeus T.
    Lenz, Teresa
    Doering, Michaela
    Holzer, Ursula
    Hartmann, Ulrike
    Kreyenberg, Hermann
    von Stackelberg, Arend
    Schrappe, Martin
    Zugmaier, Gerhard
    Feuchtinger, Tobias
    Lang, Peter
    Handgretinger, Rupert
    Ebinger, Martin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (04) : 473 - 483
  • [23] Phase 1 study of clofarabine in pediatric patients with relapsed/refractory acute lymphoblastic leukemia in Japan
    Katsuyoshi Koh
    Chitose Ogawa
    Yasuhiro Okamoto
    Kazuko Kudo
    Jiro Inagaki
    Tsuyoshi Morimoto
    Hideya Mizukami
    Evelyne Ecstein-Fraisse
    Atsushi Kikuta
    International Journal of Hematology, 2016, 104 : 245 - 255
  • [24] Phase 1 study of clofarabine in pediatric patients with relapsed/refractory acute lymphoblastic leukemia in Japan
    Koh, Katsuyoshi
    Ogawa, Chitose
    Okamoto, Yasuhiro
    Kudo, Kazuko
    Inagaki, Jiro
    Morimoto, Tsuyoshi
    Mizukami, Hideya
    Ecstein-Fraisse, Evelyne
    Kikuta, Atsushi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 104 (02) : 245 - 255
  • [25] Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia (R/R ALL).
    Bhojwani, Deepa
    Sposto, Richard
    Shah, Nirali
    Rodriguez, Vilmarie
    O'Brien, Maureen Megan
    McNeer, Jennifer Lynn
    Loh, Mignon L.
    Rheingold, Susan R.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [26] CAR T-Cell Therapy Pediatric patients with relapsed and refractory acute lymphoblastic leukemia
    Callahan, Colleen
    Baniewicz, Diane
    Ely, Beth
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2017, 21 (02) : 22 - 28
  • [27] Venetoclax and Navitoclax in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
    Alexander, Thomas
    Lacayo, Norman J.
    Pullarkat, Vinod A.
    Jabbour, Elias J.
    Khaw, Seong Lin
    Mullighan, Charles G.
    Bajel, Ashish
    Leonard, Jessica
    Norris, Robin
    Rubnitz, Jeffrey
    Vear, Susan I.
    Schmidt, Michelle
    Tong, Bo
    Zhou, Ying
    Ross, Jeremy A.
    Rosenwinkel, Lindsey
    Jacobson, Amanda
    Kim, Su Young
    Stock, Wendy
    BLOOD, 2018, 132
  • [28] Semi-mechanistic Pharmacokinetic/Pharmacodynamic model of three pegylated rHuEPO and ior®EPOCIM in New Zealand rabbits
    Reynaldo-Fernandez, G.
    Solozabal, J.
    Amaro, D.
    Fernandez-Sanchez, E. M.
    Rodriguez-Vera, L.
    Bermejo, M.
    Mangas-Sanjuan, V.
    Troconiz, I. F.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 120 : 123 - 132
  • [29] Population pharmacokinetic modelling, Monte Carlo simulation and semi-mechanistic pharmacodynamic modelling as tools to personalize gentamicin therapy
    Llanos-Paez, C. C.
    Hennig, S.
    Staatz, C. E.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (03) : 639 - 667
  • [30] A phase I and pharmacodynamic study of sequential topotecan and etoposide in patients with relapsed or refractory acute myelogenous and lymphoblastic leukemia
    Cooper, BW
    Donaher, E
    Lazarus, HM
    Green, SB
    Gosky, DM
    Rosenthal, NS
    Berger, SJ
    Li, XL
    Ingalls, ST
    Hoppel, CL
    Gerson, SL
    LEUKEMIA RESEARCH, 2003, 27 (01) : 35 - 44
12345